• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图筛查项目有助于识别伴有和不伴有支气管肺发育不良的极低出生体重儿的肺动脉高压:一项单中心经验。

An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience.

机构信息

Division of Neonatology, Children's Hospital, University of Cologne, Cologne, Germany.

出版信息

Neonatology. 2018;113(1):81-88. doi: 10.1159/000480694. Epub 2017 Nov 8.

DOI:10.1159/000480694
PMID:29131022
Abstract

BACKGROUND

Pulmonary hypertension (PH) affects 1 in 6 infants with a birthweight <1,000 g (extremely low birthweight; ELBW) and is frequently associated with bronchopulmonary dysplasia (BPD). If untreated, the mortality rates of the disease are high.

OBJECTIVES

The aim of this study was to characterize risk factors for PH in ELBW infants and to describe the timing of onset of the disease by setting up a screening program.

METHODS

ELBW infants treated at the Department of Neonatology (level III neonatal intensive care unit at the University of Cologne Medical Centre, Germany) between January 2010 and March 2015 were included. Echocardiography screening for PH was performed either before discharge or if BPD was diagnosed. Additionally, infants had at least 1 echocardiographic scan after discharge. Survival with PH, age at diagnosis of PH, and risk factors associated with PH were assessed.

RESULTS

In total, 34/188 (18%) infants had PH. Of these, 14 (41%) were identified after discharge. Another 11 (32%) were diagnosed with PH without suffering from moderate or severe BPD. The risk factors for diagnosis of PH were moderate (odds ratio, OR 4 [2-8]) or severe BPD (OR 13 [2-71]), prolonged rupture of membranes >7 days (OR 5 [1-19]), and birthweight below the 3rd percentile (OR 3 [1-9]). All infants with PH before discharge and 50% diagnosed after discharge were treated with sildenafil (2.0 mg/kg/day). PH resolved and sildenafil was discontinued in all patients after a median duration of 13 months (IQR 8-20).

CONCLUSIONS

An echocardiographic screening program may help to identify infants with PH. Examinations should include all ELBW infants irrespective of the presence of BPD and be continued after discharge.

摘要

背景

肺动脉高压(PH)影响体重<1000g(极低出生体重;ELBW)的婴儿中的 1/6,并且常与支气管肺发育不良(BPD)相关。如果不治疗,疾病的死亡率很高。

目的

本研究旨在描述 ELBW 婴儿 PH 的危险因素,并通过建立筛查计划描述疾病的发病时间。

方法

纳入 2010 年 1 月至 2015 年 3 月在德国科隆大学医学中心新生儿科(三级新生儿重症监护病房)接受治疗的 ELBW 婴儿。PH 的超声心动图筛查在出院前或诊断出 BPD 时进行。此外,婴儿出院后至少进行 1 次超声心动图检查。评估 PH 存活、PH 诊断年龄和与 PH 相关的危险因素。

结果

共有 34/188(18%)婴儿患有 PH。其中,14 例(41%)在出院后被发现。另有 11 例(32%)在没有中重度 BPD 的情况下被诊断为 PH。诊断 PH 的危险因素是中度(比值比,OR 4 [2-8])或重度 BPD(OR 13 [2-71])、胎膜早破>7 天(OR 5 [1-19])和出生体重低于第 3 百分位(OR 3 [1-9])。所有在出院前患有 PH 的婴儿和 50%在出院后被诊断为 PH 的婴儿均接受了西地那非(2.0mg/kg/天)治疗。中位治疗时间为 13 个月(IQR 8-20)后,所有患者的 PH 均得到缓解,且停用了西地那非。

结论

超声心动图筛查方案可能有助于识别 PH 婴儿。检查应包括所有 ELBW 婴儿,无论是否存在 BPD,并在出院后继续进行。

相似文献

1
An Echocardiographic Screening Program Helps to Identify Pulmonary Hypertension in Extremely Low Birthweight Infants with and without Bronchopulmonary Dysplasia: A Single-Center Experience.超声心动图筛查项目有助于识别伴有和不伴有支气管肺发育不良的极低出生体重儿的肺动脉高压:一项单中心经验。
Neonatology. 2018;113(1):81-88. doi: 10.1159/000480694. Epub 2017 Nov 8.
2
Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.西地那非治疗支气管肺发育不良相关肺动脉高压的婴儿
Hosp Pediatr. 2016 Jan;6(1):27-33. doi: 10.1542/hpeds.2015-0076. Epub 2015 Jan 1.
3
Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.新生儿科医生行超声心动图随访时发现肺动脉高压合并支气管肺发育不良。
Eur J Pediatr. 2021 Jun;180(6):1711-1720. doi: 10.1007/s00431-021-03954-y. Epub 2021 Jan 21.
4
[Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].[早产儿支气管肺发育不良相关肺动脉高压的危险因素及预后]
Zhonghua Er Ke Za Zhi. 2020 Sep 2;58(9):747-752. doi: 10.3760/cma.j.cn112140-20200327-00310.
5
Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation.超声心动图检测支气管肺发育不良且需长时间正压通气的极低出生体重儿肺动脉高压
J Perinatol. 2011 Oct;31(10):635-40. doi: 10.1038/jp.2010.213. Epub 2011 Feb 10.
6
Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.西地那非用于治疗支气管肺发育不良婴儿的肺动脉高压
Pediatr Cardiol. 2015 Aug;36(6):1255-60. doi: 10.1007/s00246-015-1154-0. Epub 2015 Apr 1.
7
Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.支气管肺发育不良婴儿的肺动脉高压特异性治疗
Pediatr Pulmonol. 2017 Jan;52(1):77-83. doi: 10.1002/ppul.23508. Epub 2016 Jun 22.
8
Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety.西地那非治疗支气管肺发育不良相关肺动脉高压:疗效与安全性的回顾性研究
Eur J Pediatr. 2015 Aug;174(8):1109-15. doi: 10.1007/s00431-015-2515-7. Epub 2015 Mar 22.
9
Pulmonary hypertension in preterm infants: results of a prospective screening program.早产儿肺动脉高压:一项前瞻性筛查项目的结果
J Perinatol. 2017 May;37(5):572-577. doi: 10.1038/jp.2016.255. Epub 2017 Feb 16.
10
Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.极早产儿肺动脉高压:呼吁规范超声心动图筛查和随访政策。
Eur J Pediatr. 2021 Jun;180(6):1855-1865. doi: 10.1007/s00431-021-03931-5. Epub 2021 Feb 2.

引用本文的文献

1
Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.极早早产儿迟发性肺动脉高压发生的相关危险因素
Pediatr Pulmonol. 2025 Feb;60(2):e27501. doi: 10.1002/ppul.27501.
2
Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors.患有肺动脉高压的早产儿的新生儿结局:基于产前危险因素的聚类。
Pediatr Res. 2024 Oct;96(5):1251-1257. doi: 10.1038/s41390-024-03232-1. Epub 2024 May 11.
3
Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
极早产儿的早期心功能与死亡、严重支气管肺发育不良和肺动脉高压。
Pediatr Res. 2024 Jan;95(1):293-301. doi: 10.1038/s41390-023-02817-6. Epub 2023 Sep 19.
4
Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.支气管肺发育不良婴儿肺动脉高压的危险因素及结局:一项荟萃分析。
Front Pediatr. 2021 Jun 25;9:695610. doi: 10.3389/fped.2021.695610. eCollection 2021.
5
Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants.早期肺动脉高压是极早产儿支气管肺发育不良相关晚期肺动脉高压的一个危险因素。
Sci Rep. 2021 May 27;11(1):11206. doi: 10.1038/s41598-021-90769-4.
6
Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.新生儿科医生行超声心动图随访时发现肺动脉高压合并支气管肺发育不良。
Eur J Pediatr. 2021 Jun;180(6):1711-1720. doi: 10.1007/s00431-021-03954-y. Epub 2021 Jan 21.
7
Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age.36 孕周后与支气管肺发育不良相关的肺动脉高压的转归。
Arch Dis Child Fetal Neonatal Ed. 2021 Jan;106(1):45-50. doi: 10.1136/archdischild-2019-318531. Epub 2020 Jun 22.
8
Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia.超声心动图在预测严重支气管肺发育不良婴儿死亡率中的应用。
J Perinatol. 2020 Jan;40(1):149-156. doi: 10.1038/s41372-019-0508-5. Epub 2019 Sep 30.